cefazolin has been researched along with Community Acquired Infection in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (47.37) | 29.6817 |
2010's | 9 (47.37) | 24.3611 |
2020's | 1 (5.26) | 2.80 |
Authors | Studies |
---|---|
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
Kaneko, H; Kawasaki, H; Maruyama, H; Nakaminami, H; Noguchi, N; Suzuki, Y; Takadama, S | 1 |
Alpay, H; Altuntaş, Ü; Bıyıklı, N; Çiçek, N; Gökçe, İ; Güven, S; Yıldız, N | 1 |
Bamal, R; Bindra, R; Matthews, J; McLean, A | 1 |
King, EA; Patel, D; Uppala, A | 1 |
Hatef, DA; Janis, JE; Reece, EM; Wong, C | 1 |
Halevy, R; Koren, A; Odetalla, A; Sakran, W; Smolkin, V | 1 |
Averbuch, D; Blich, O; Breuer, O; Cohen-Cymberknoh, M; Kerem, E; Kharasch, S; Shoseyov, D | 1 |
Gao, L; Hao, FL; Lyu, Y; Wei, MJ; Zhang, P; Zhu, Y | 1 |
De'Angelis, C; Elligsen, M; Lathia, N; LePiane, F; Simor, A; Walker, SA; Walker, SE | 1 |
Chen, PL; Hung, YP; Ko, WC; Wu, YH | 1 |
Arnold, FW; Wojda, B | 1 |
Chen, JY; Chen, PS; Chen, YP; Lee, WT; Lin, LJ | 1 |
Donaldson, A; Gosbell, IB | 1 |
Bothwell, NE; Cable, BB; Shvidler, J | 1 |
Hsueh, PR; Huang, LM; Lee, CY; Lee, PI; Luh, KT; Teng, LJ; Tsai, HY | 1 |
Feder, HM | 1 |
Adderson, E; Carroll, K; Christenson, J; Davis, R; Leonard, R; Pavia, A | 1 |
Barnes, DJ; Dobbin, CJ; Duggan, CJ | 1 |
2 trial(s) available for cefazolin and Community Acquired Infection
Article | Year |
---|---|
Does empiric antibiotic therapy change MRSA [corrected] hand infection outcomes? Cost analysis of a randomized prospective trial in a county hospital.
Topics: Abscess; Adult; Anti-Bacterial Agents; Cefazolin; Community-Acquired Infections; Cost-Benefit Analysis; Costs and Cost Analysis; Female; Hand; Hospital Costs; Hospitals, County; Humans; Length of Stay; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Soft Tissue Infections; Staphylococcal Infections; Vancomycin | 2014 |
A Pharmacokinetic and Pharmacodynamic Study on Intravenous Cefazedone Sodium in Patients with Community-acquired Pneumonia.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefazolin; Community-Acquired Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2015 |
17 other study(ies) available for cefazolin and Community Acquired Infection
Article | Year |
---|---|
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Possible Dissemination of a Panton-Valentine Leukocidin-Positive Livestock-Associated Methicillin-Resistant Staphylococcus aureus CC398 Clone in Tokyo, Japan.
Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Cattle; Cefazolin; Community-Acquired Infections; Exotoxins; Humans; Japan; Leukocidins; Livestock; Male; Methicillin-Resistant Staphylococcus aureus; Molecular Epidemiology; Poultry; Staphylococcal Infections; Swine; Tokyo; Treatment Outcome | 2021 |
Changes in Bacterial Resistance Patterns of Pediatric Urinary Tract Infections and Rationale for Empirical Antibiotic Therapy.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cefazolin; Cefixime; Ceftriaxone; Cefuroxime; Child; Child, Preschool; Ciprofloxacin; Community-Acquired Infections; Cross-Sectional Studies; Drug Combinations; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Humans; Infant; Male; Pediatrics; Retrospective Studies; Sulfamethizole; Trimethoprim; Turkey; Urinary Tract Infections | 2017 |
Bacteriological profile of community-acquired musculoskeletal infections: a study from Queensland.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Arthritis, Infectious; Australia; Cefazolin; Child; Child, Preschool; Community-Acquired Infections; Female; Floxacillin; Hospitalization; Humans; Infant; Infant, Newborn; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Musculoskeletal Diseases; Osteomyelitis; Queensland; Retrospective Studies; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Young Adult | 2018 |
Cefazolin versus fluoroquinolones for the treatment of community-acquired urinary tract infections in hospitalized patients.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefazolin; Clostridium Infections; Community-Acquired Infections; Female; Fluoroquinolones; Hospitalization; Humans; Inpatients; Length of Stay; Male; Middle Aged; Retrospective Studies; Treatment Failure; Treatment Outcome; Urinary Tract Infections | 2019 |
Community-acquired urinary tract infection in hospitalized children: etiology and antimicrobial resistance. A comparison between first episode and recurrent infection.
Topics: Anti-Bacterial Agents; Cefazolin; Cefuroxime; Child, Hospitalized; Child, Preschool; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia coli; Female; Gentamicins; Humans; Infant; Israel; Male; Pseudomonas aeruginosa; Recurrence; Retrospective Studies; Risk Factors; Urinary Tract Infections | 2015 |
Antibiotic treatment for children hospitalized with community-acquired pneumonia after oral therapy.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Ambulatory Care; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Cefuroxime; Child; Child, Preschool; Community-Acquired Infections; Female; Fever; Hospitalization; Humans; Infant; Length of Stay; Linear Models; Logistic Models; Male; Multivariate Analysis; Penicillins; Pneumonia, Bacterial; Retrospective Studies | 2015 |
Comparison of mortality between nosocomial and community-acquired febrile neutropenia patients treated initially with cefazolin plus tobramycin: retrospective chart review.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefazolin; Cohort Studies; Community-Acquired Infections; Cross Infection; Female; Fever of Unknown Origin; Humans; Incidence; Male; Middle Aged; Neutropenia; Retrospective Studies; Survival Analysis; Tobramycin; Young Adult | 2012 |
Risk factors and clinical impact of levofloxacin or cefazolin nonsusceptibility or ESBL production among uropathogens in adults with community-onset urinary tract infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cefazolin; Community-Acquired Infections; Comorbidity; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Levofloxacin; Male; Middle Aged; Prospective Studies; Risk Factors; Taiwan; Urinary Tract Infections; Young Adult | 2014 |
An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Clindamycin; Community-Acquired Infections; Erythromycin; Female; Humans; Kentucky; Levofloxacin; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Oxacillin; Rifampin; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Tetracycline; Trimethoprim; Vancomycin | 2005 |
Community-acquired Klebsiella oxytoca endocarditis: a case report.
Topics: Aged; Anti-Bacterial Agents; Cefazolin; Community-Acquired Infections; Endocarditis, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella oxytoca | 2006 |
An African strain of community methicillin-resistant Staphylococcus aureus in a Burundi refugee.
Topics: Anti-Bacterial Agents; Australia; Bacterial Proteins; Burundi; Cefazolin; Clindamycin; Community-Acquired Infections; Humans; Methicillin Resistance; Middle Aged; Penicillin-Binding Proteins; Refugees; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Wound Infection | 2006 |
Acute rise in methicillin-resistant Staphylococcus aureus infections in a coastal community.
Topics: Abscess; Adolescent; Adult; Aged; Cefazolin; Cephalosporin Resistance; Child; Child, Preschool; Community-Acquired Infections; Ear Diseases; Facial Dermatoses; Female; Hawaii; Humans; Incidence; Infant; Male; Methicillin Resistance; Middle Aged; Neck; Nose Diseases; Otorhinolaryngologic Diseases; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2007 |
Bacteremic pneumonia caused by a single clone of Streptococcus pneumoniae with different optochin susceptibilities.
Topics: Bacteremia; Bacterial Typing Techniques; Cefazolin; Cephalexin; Child, Preschool; Clone Cells; Community-Acquired Infections; Electrophoresis, Gel, Pulsed-Field; Humans; Male; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Quinine; Random Amplified Polymorphic DNA Technique; Serotyping; Streptococcus pneumoniae | 2000 |
Methicillin-resistant Staphylococcus aureus infections in 2 pediatric outpatients.
Topics: Ambulatory Care; Anti-Bacterial Agents; Cefazolin; Cephalexin; Cephalosporins; Child; Clindamycin; Community-Acquired Infections; Drainage; Female; Hospitalization; Humans; Infant; Methicillin Resistance; Neck; Staphylococcal Infections; Staphylococcus aureus; Toes; Treatment Failure; Vancomycin | 2000 |
A community pseudo-outbreak of invasive Staphylococcus aureus infection.
Topics: Adolescent; Anti-Bacterial Agents; Cefazolin; Clindamycin; Community-Acquired Infections; Disease Outbreaks; DNA, Bacterial; Erythromycin; Gentamicins; Humans; Male; Methicillin Resistance; Nafcillin; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination | 2000 |
The efficacy of an antibiotic protocol for community-acquired pneumonia.
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Clinical Protocols; Community-Acquired Infections; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Erythromycin; Female; Hospital Mortality; Humans; Injections, Intravenous; Male; Middle Aged; New South Wales; Penicillin G; Penicillins; Pneumonia; Prognosis; Retrospective Studies; Statistics, Nonparametric; Treatment Outcome | 2001 |